Wilkinson GR - Search Results

1

Comparison of the dapsone recovery ratio and the erythromycin breath test as in vivo probes of CYP3A activity in patients with rheumatoid arthritis receiving cyclosporine.

Stein CM, Kinirons MT, Pincus T, Wilkinson GR, Wood AJ. Stein CM, et al. Among authors: wilkinson gr. Clin Pharmacol Ther. 1996 Jan;59(1):47-51. doi: 10.1016/S0009-9236(96)90023-5. Clin Pharmacol Ther. 1996. PMID: 8549033

2

The erythromycin breath test reflects P-glycoprotein function independently of cytochrome P450 3A activity.

Kurnik D, Wood AJ, Wilkinson GR. Kurnik D, et al. Among authors: wilkinson gr. Clin Pharmacol Ther. 2006 Sep;80(3):228-34. doi: 10.1016/j.clpt.2006.06.002. Clin Pharmacol Ther. 2006. PMID: 16952489 Clinical Trial.

3

Influence of debrisoquin phenotype on the inducibility of propranolol metabolism.

Shaheen O, Biollaz J, Koshakji RP, Wilkinson GR, Wood AJ. Shaheen O, et al. Among authors: wilkinson gr. Clin Pharmacol Ther. 1989 Apr;45(4):439-43. doi: 10.1038/clpt.1989.52. Clin Pharmacol Ther. 1989. PMID: 2702801

4

Absence of correlations among three putative in vivo probes of human cytochrome P4503A activity in young healthy men.

Kinirons MT, O'Shea D, Downing TE, Fitzwilliam AT, Joellenbeck L, Groopman JD, Wilkinson GR, Wood AJ. Kinirons MT, et al. Among authors: wilkinson gr. Clin Pharmacol Ther. 1993 Dec;54(6):621-9. doi: 10.1038/clpt.1993.199. Clin Pharmacol Ther. 1993. PMID: 8275617

5

Differences between white subjects and Chinese subjects in the in vivo inhibition of cytochrome P450s 2C19, 2D6, and 3A by omeprazole.

Caraco Y, Wilkinson GR, Wood AJ. Caraco Y, et al. Among authors: wilkinson gr. Clin Pharmacol Ther. 1996 Oct;60(4):396-404. doi: 10.1016/S0009-9236(96)90196-4. Clin Pharmacol Ther. 1996. PMID: 8873687 Clinical Trial.

6

Effects of ketoconazole on the erythromycin breath test and the dapsone recovery ratio.

Kinirons MT, Krivoruk Y, Wilkinson GR, Wood AJ. Kinirons MT, et al. Among authors: wilkinson gr. Br J Clin Pharmacol. 1999 Feb;47(2):223-5. doi: 10.1046/j.1365-2125.1999.00859.x. Br J Clin Pharmacol. 1999. PMID: 10190659 Free PMC article. Clinical Trial. No abstract available.

7

Genetic polymorphism of (S)-mephenytoin 4'-hydroxylation in populations of African descent.

Xie HG, Kim RB, Stein CM, Wilkinson GR, Wood AJ. Xie HG, et al. Among authors: wilkinson gr. Br J Clin Pharmacol. 1999 Sep;48(3):402-8. doi: 10.1046/j.1365-2125.1999.00009.x. Br J Clin Pharmacol. 1999. PMID: 10510153 Free PMC article.

8

Failure of erythromycin breath test to correlate with midazolam clearance as a probe of cytochrome P4503A.

Kinirons MT, O'Shea D, Kim RB, Groopman JD, Thummel KE, Wood AJ, Wilkinson GR. Kinirons MT, et al. Among authors: wilkinson gr. Clin Pharmacol Ther. 1999 Sep;66(3):224-31. doi: 10.1016/S0009-9236(99)70029-9. Clin Pharmacol Ther. 1999. PMID: 10511057 Clinical Trial.

9

CYP3A activity in African American and European American men: population differences and functional effect of the CYP3A4*1B5'-promoter region polymorphism.

Wandel C, Witte JS, Hall JM, Stein CM, Wood AJ, Wilkinson GR. Wandel C, et al. Among authors: wilkinson gr. Clin Pharmacol Ther. 2000 Jul;68(1):82-91. doi: 10.1067/mcp.2000.108506. Clin Pharmacol Ther. 2000. PMID: 10945319

10

Genetic variability in CYP3A5 and its possible consequences.

Xie HG, Wood AJ, Kim RB, Stein CM, Wilkinson GR. Xie HG, et al. Among authors: wilkinson gr. Pharmacogenomics. 2004 Apr;5(3):243-72. doi: 10.1517/phgs.5.3.243.29833. Pharmacogenomics. 2004. PMID: 15102541 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

239 results

Search Page